| Cancer immunoediting: from immune surveillance to immune escape R Kim Cancer Immunotherapy, 9-27, 2007 | 1619 | 2007 |
| Tumor-driven evolution of immunosuppressive networks during malignant progression R Kim, M Emi, K Tanabe, K Arihiro Cancer research 66 (11), 5527-5536, 2006 | 585 | 2006 |
| Role of mitochondria as the gardens of cell death R Kim, M Emi, K Tanabe Cancer chemotherapy and pharmacology 57, 545-553, 2006 | 398 | 2006 |
| Current status of the molecular mechanisms of anticancer drug-induced apoptosis: the contribution of molecular-level analysis to cancer chemotherapy R Kim, K Tanabe, Y Uchida, M Emi, H Inoue, T Toge Cancer chemotherapy and pharmacology 50, 343-352, 2002 | 380 | 2002 |
| Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis A Tsuburaya, J Mizusawa, Y Tanaka, N Fukushima, A Nashimoto, ... Journal of British Surgery 101 (6), 653-660, 2014 | 356 | 2014 |
| Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer T Yoshikawa, M Sasako, S Yamamoto, T Sano, H Imamura, K Fujitani, ... Journal of British Surgery 96 (9), 1015-1022, 2009 | 296 | 2009 |
| Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START) W Koizumi, YH Kim, M Fujii, HK Kim, H Imamura, KH Lee, T Hara, ... Journal of cancer research and clinical oncology 140, 319-328, 2014 | 214 | 2014 |
| Caspase-dependent and-independent cell death pathways after DNA damage R Kim, M Emi, K Tanabe Oncology reports 14 (3), 595-599, 2005 | 200 | 2005 |
| The role of Fas ligand and transforming growth factor β in tumor progression: Molecular mechanisms of immune privilege via Fas‐mediated apoptosis and potential targets for … R Kim, M Emi, K Tanabe, Y Uchida, T Toge Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 175 | 2004 |
| Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy R Kim, M Emi, K Tanabe, T Toge Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 168 | 2004 |
| The long-term survival of stage IV gastric cancer patients with conversion therapy K Yamaguchi, K Yoshida, T Tanahashi, T Takahashi, N Matsuhashi, ... Gastric Cancer 21, 315-323, 2018 | 167 | 2018 |
| Targeted therapy against Bcl-2-related proteins in breast cancer cells M Emi, R Kim, K Tanabe, Y Uchida, T Toge Breast cancer research 7, 1-13, 2005 | 164 | 2005 |
| Overall diagnosis apparatus for vehicle-mounted control devices K Ina, Y Hirabayashi, K Minami, K Ito, S Akiyama, H Tanabe US Patent 4,843,557, 1989 | 148 | 1989 |
| Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses R Kim, M Emi, K Tanabe Cancer biology & therapy 4 (9), 924-933, 2005 | 145 | 2005 |
| Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial … A Tsuburaya, K Yoshida, M Kobayashi, S Yoshino, M Takahashi, ... The Lancet Oncology 15 (8), 886-893, 2014 | 135 | 2014 |
| Neutrophil elastase induces cell proliferation and migration by the release of TGF-α, PDGF and VEGF in esophageal cell lines Y Wada, K Yoshida, Y Tsutani, H Shigematsu, M Oeda, Y Sanada, ... Oncology reports 17 (1), 161-167, 2007 | 127 | 2007 |
| Synergistic effects of docetaxel and S‐1 by modulating the expression of metabolic enzymes of 5‐fluorouracil in human gastric cancer cell lines Y Wada, K Yoshida, T Suzuki, H Mizuiri, K Konishi, K Ukon, K Tanabe, ... International journal of cancer 119 (4), 783-791, 2006 | 99 | 2006 |
| Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide … J Fujita, M Takahashi, T Urushihara, K Tanabe, Y Kodera, T Yumiba, ... Gastric Cancer 19, 302-311, 2016 | 88 | 2016 |
| Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial T Yoshikawa, K Tanabe, K Nishikawa, Y Ito, T Matsui, Y Kimura, ... Annals of surgical oncology 21, 213-219, 2014 | 85 | 2014 |
| The role of apoptosis in cancer cell survival and therapeutic outcome R Kim, M Emi, K Tanabe Cancer biology & therapy 5 (11), 1429-1442, 2006 | 79 | 2006 |
